Stock Markets August 3, 2026 07:52 AM

Futures Rise as Iran Talks Loom; Supernus-Indivior Merger Drives Premarket Gains, GameStop Falls

Renewed diplomatic overtures lift risk appetite while a wave of company-specific moves reshapes early trading

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
SUPN INDV FERG CRCL

U.S. stock futures climbed on Monday after President Donald Trump said talks with Iran would begin this week, easing recent geopolitical tensions and bolstering risk appetite. Technology names attempted to recover following a steep July pullback. In premarket action, Supernus Pharmaceuticals jumped on a merger announcement with Indivior, Ferguson rose ahead of an S&P 500 inclusion, while GameStop and several technology and EV-related stocks slipped.

Futures Rise as Iran Talks Loom; Supernus-Indivior Merger Drives Premarket Gains, GameStop Falls
SUPN INDV FERG CRCL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • U.S. futures rose after President Trump said negotiations with Iran would begin this week, reducing a source of geopolitical risk.
  • Supernus agreed to merge with Indivior in an all-stock merger of equals; Supernus shareholders will receive 1.5401 Indivior shares and Indivior shareholders will receive a $1 billion special dividend before closing.
  • Company-specific events influenced premarket activity across several sectors, including pharmaceuticals, building products distribution, semiconductors, electric vehicles, and medical devices.

U.S. equity futures moved higher in early trading on Monday after President Donald Trump said negotiations with Iran were set to begin this week, easing geopolitical worries that had pressured markets in recent sessions. Investors also weighed mixed signals from artificial intelligence-linked stocks as the sector digested a volatile earnings period.

By 07:11 ET (11:11 GMT), S&P 500 futures were up 40 points, or 0.5%. Nasdaq 100 futures had added 74 points, or 0.3%, while Dow Jones Industrial Average futures rose 482 points, or 0.9%.


Premarket movers

Several individual-company developments shaped early premarket trading.

  • Supernus Pharmaceuticals surged 20.7% after the company agreed to an all-stock merger of equals with Indivior Pharmaceuticals. Under the arrangement, Supernus shareholders will receive 1.5401 Indivior shares for each Supernus share they hold. Indivior shareholders are set to receive a $1 billion special cash dividend prior to closing. The combined company will adopt the Supernus name and continue trading under the SUPN ticker.
  • Ferguson climbed 7.1% as market participants positioned ahead of the building products distributor’s planned inclusion in the S&P 500, which is scheduled to take effect before trading opens on Aug. 5. Market watchers expect that passive funds and ETFs that track the benchmark will purchase shares to mirror the index change.
  • Circle Internet Group fell 5.5% after Morgan Stanley downgraded the stablecoin issuer to Underweight from Equalweight and cut its price target to $38 from $106. The brokerage cautioned that slower growth in USDC supply could expose Circle’s dependence on reserve income, prompting downward revisions to earnings forecasts through 2028.
  • GameStop slipped 6% following announcements that the videogame retailer reached agreements with existing noteholders to exchange roughly $1.4 billion of convertible debt for newly issued Class A common stock. The debt-for-equity swap will not produce cash proceeds for the company but will substantially reduce its outstanding convertible obligations.
  • Micron Technology eased 2% after Citi removed the memory chipmaker from its catalyst watch list, citing mixed quarterly results from memory semiconductor peers that clouded the near-term sector outlook.
  • XPeng declined 3.5% after reporting July deliveries of 38,027 vehicles. While that figure represented a 4% year-over-year increase, investors reacted negatively to the monthly tally for failing to sustain the stronger momentum the company posted in the second quarter.
  • Ceribell rose 3% after the U.S. Centers for Medicare & Medicaid Services approved a New Technology Add-on Payment for the company’s Delirium Monitor System. The reimbursement can be worth up to $2,171 per eligible Medicare patient case, will take effect on Oct. 1, and follows the device’s FDA clearance late last year.

Market context

The prospect of renewed diplomacy appeared to improve investor risk appetite, even as market participants continued to assess the outlook for AI-linked names after a turbulent earnings stretch. Company-specific events - mergers, index inclusions, analyst downgrades, delivery numbers, and regulatory reimbursement decisions - dominated premarket headlines and drove wide-ranging moves across sectors including pharmaceuticals, building products distribution, semiconductors, electric vehicles, and medical devices.

Note: All price moves and corporate actions referenced are based on premarket trading and company announcements disclosed this morning.

Risks

  • Artificial intelligence-linked stocks remain under scrutiny after a volatile earnings season, creating uncertainty for the technology sector and related indices.
  • Morgan Stanley's downgrade of Circle highlighted the risk that slowing USDC supply could pressure the stablecoin issuer's revenue and earnings through 2028, affecting fintech and crypto-adjacent firms.
  • Monthly delivery figures that fall short of recent momentum, as seen with XPeng, can derail investor expectations in the electric vehicle sector and weigh on stock performance.

More from Stock Markets

Lockheed Martin vs RTX: a deep dive on valuation, capital returns and which defense name is the cleaner value Aug 3, 2026 Restaurant Stocks Slide After Michigan Cyclospora Outbreak Claims Two Lives Aug 3, 2026 Citi names Bank of America veteran Rohan Sen to lead technology services coverage Aug 3, 2026 FAA Clears Boeing 737 MAX-7 for Production After Prolonged Review, Shares Jump 5% Aug 3, 2026 VF Corp CEO Buys Into Post-earnings Drop; Insider Move Tests Patience of Turnaround Investors Aug 3, 2026